Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Insecticide danger to bees addressed
European report looks at chemical risk

A report by the European Food Safety Authority (EFSA) has deemed the world's most widely-used insecticide an unacceptable danger to bees.

The report was demanded by the European commission in April, following two major studies earlier in the spring that found a link between the use of neonicotinoids and the UK's decline in bees. Further studies have been produced since.

Bees and other pollinators are critical to one-third of all food, therefore, the report examined the risk posed by the chemicals, including the widely-used insecticide, imidacloprid.

Working together with experts from across Europe, EFSA's report concluded that the use of imidacloprid would only be considered acceptable on crops that honeybees are not attracted to.

EFSA added that it found a widespread lack of information in many areas, earlier stating that current "simplistic" regulations contained "major weaknesses".

Andrew Pendleton, of Friends of the Earth, said: "This is a major turning point in the battle to save our bees. EFSA have sounded the death knell for one of the chemicals most frequently linked to bee decline and cast serious doubt over the safety of the whole neonicotinoid family."

However, a spokesperson for the company that produces imidaclopid, said: "The company is ready to work with the European commission and member states to address the perceived data gaps.

"We believe it is very important that any political decision relating to registrations of neonicotinoid-containing products should be based on clear, scientific evidence of adverse effects."

 

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk